Cost of hospitalizations associated with sickle cell disease in the United States.
This study estimated the number and cost of hospitalizations associated with sickle cell disease in the United States.
To estimate the number of hospitalizations per year in the United States of people with sickle cell disease, the authors used data for the years 1989 through 1993 from national hospital discharge surveys conducted by the National Center for Health Statistics.
The authors derived cost estimates using data from a 1992 national hospital discharge survey conducted by the Agency for Health Care Policy and Research and a 1992 survey of physicians conducted by the American Medical Association.
During the years 1989 through 1993, there were on average an estimated 75,000 hospitalizations per year of children and adults with sickle cell disease.
The average direct cost per hospitalization (in 1996 dollars) was estimated at $6300, for a total direct cost of $475 million per year.
In 66% of hospital discharge records, govemment programs were listed as the expected principal source of payment.
The cost of hospitalizations associated with sickle cell disease is substantial.
Because govemment programs pay most of this cost, further government-funded research to develop interventions that prevent complications ofthe disease has great potential for cost savings as well as for reducing the suffering of those afflicted with this painful genetic disorder. (...)
Mots-clés Pascal : Anémie hématie falciforme, Hospitalisation, Economie santé, Analyse coût, Homme, Etats Unis, Amérique du Nord, Amérique, Hémopathie, Anémie hémolytique, Hémoglobinopathie, Maladie héréditaire
Mots-clés Pascal anglais : Sickle cell anemia, Hospitalization, Health economy, Cost analysis, Human, United States, North America, America, Hemopathy, Hemolytic anemia, Hemoglobinopathy, Genetic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0172910
Code Inist : 002B19A01. Création : 21/05/1997.